课题基金 / 基金详情

Behavior Measure for Children and Adolescents with Down Syndrome

Behavior Measure for Children and Adolescents with Down Syndrome
唐氏综合症儿童和青少年的行为测量
批准号:
10441731
负责人:
Anna J. Esbensen
金额:
$68.79万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-15 至 2027-08-31

项目摘要

项目成果

Anna J. Esbensen的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 在行为结果测量的可用性方面存在着根本性的差距,这些测量是适当的,可靠的, 并且对患有唐氏综合症(DS)的儿童有效。缺乏这种成果衡量标准, 识别行为问题,测量治疗效果和解释临床 旨在改善DS患者生活的试验。没有基于证据的行为结果 由于研究不足,该人群的措施、干预措施和治疗试验仍将是次优的。 措施NICHD召集的DS领域主要专家工作组指出, 行为问题被评估为适当的或被验证用于患有DS的个体。整体 本申请的目的是开发和验证一种新的行为关注度量,即行为 唐氏综合征量表(BIDS),可用于研究,临床实践和治疗研究 重点是儿童和青少年与DS年龄2-17岁,在英语和西班牙语。我们的理由是 在这个人群中,DS与一种独特的神经行为表型有关,但关键是 DS患者中常见的关注行为从目前可用的测量中被忽略, 行为上的担忧因此,BIDS上的拟议项目将纳入家庭提出的行为问题 以及与DS儿童相关的临床实践。我们提出了三个具体目标:1)展示 在英语和西班牙语中DS儿童和青少年中BIDS的心理测量学特性, 确定BIDS测量模型,建立信度(重测信度和评分者间信度), 效度(内部效度和结构效度)2)评估测量的心理测量特性的差异, 所选人口统计学和临床特征的变化函数,以及3)表征 在患有DS的儿童和青少年中随时间推移的BIDS,为临床试验提供比较数据。到 为了实现这些目标,我们将用英语和西班牙语进行在线、电话和书面调查, 以英语或西班牙语口译员进行评估,针对2-17岁的DS儿童。我们 研究团队是唯一定位进行这项工作,结合专业知识,在DS,措施 发展/评估、拉丁裔人群、心理评估和共病医学状况。我们 预计这项测量研究将为未来的疗效和有效性试验提供重要指导。 我们的目标与INCLUDE项目的研究重点一致,即扩大DS患者的纳入范围, 临床试验,为这一人群制定适当的行为措施。随着我们的领域继续 开发新的药物和临床干预措施,我们的项目将支持这项工作,并对 生活在美国的40万DS患者。
英文摘要
PROJECT SUMMARY There is a fundamental gap in the availability of behavioral outcome measures that are appropriate, reliable, and valid for use with children with Down syndrome (DS). Lack of such outcome measures represents an important problem to identifying behavioral concerns, measuring treatment effects, and interpreting clinical trials aimed at improving the lives of individuals with DS. Without evidence-based behavioral outcome measures, interventions and treatment trials in this population will remain suboptimal due to poor study measures. Working groups convened by NICHD of leading experts in DS identified that no measure of behavioral concerns was evaluated as appropriate or validated for use with individuals with DS. The overall objective of this application is to develop and validate a novel measure of behavioral concerns, the Behavior Inventory for Down Syndrome (BIDS), that can be used in research, clinical practice, and treatment studies focused on children and adolescents with DS ages 2-17 years, in both English and Spanish. Our rationale for working with this population is that DS is associated with a distinct neurobehavioral phenotype, yet key behaviors of concern common in individuals with DS are omitted from currently available measures of behavioral concerns. Thus, proposed items on the BIDS will incorporate behavioral concerns raised by families and in clinical practice related to children with DS. We propose three specific aims: 1) demonstrate the psychometric properties of the BIDS among children and adolescents with DS in English and Spanish by identifying the BIDS measurement model, establishing reliability (test-retest and inter-rater reliability) and validity (internal and construct validity) 2) evaluating differences in the measure’s psychometric properties as a function of variation in selected demographic and clinical characteristics, and 3) characterize the trajectory of the BIDS over time among children and adolescents with DS to provide comparative data for clinical trials. To achieve these aims, we will conduct online, phone, and paper surveys in English and Spanish, and in-person assessments in English or with Spanish-speaking interpreters, targeting children ages 2-17 years with DS. Our research team is uniquely positioned to conduct this work, combining expertise in DS, measure development/evaluation, Latinx populations, psychological assessment, and comorbid medical conditions. We anticipate that this measurement study will provide critical guidance for future efficacy and effectiveness trials. Our goals are in line with the INCLUDE Project research priority to expand inclusion of individuals with DS in clinical trials by developing appropriate measures of behavior for this population. As our field continues to develop new pharmaceutical and clinical interventions, our project will support this work and have an impact on the 400,000 individuals with DS living in the United States.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Behavior Measure for Children and Adolescents with Down Syndrome
  • 批准号:
    10704586
  • 项目类别:
  • 资助金额:
    $71.05万
  • 财政年份:
    2022
  • 负责人:
    Anna J. Esbensen
  • 依托单位:
Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome
  • 批准号:
    10022154
  • 项目类别:
  • 资助金额:
    $67.59万
  • 财政年份:
    2019
  • 负责人:
    Anna J. Esbensen
  • 依托单位:
Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome
  • 批准号:
    10441697
  • 项目类别:
  • 资助金额:
    $16.46万
  • 财政年份:
    2019
  • 负责人:
    Anna J. Esbensen
  • 依托单位:
Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome
  • 批准号:
    10704179
  • 项目类别:
  • 资助金额:
    $106.77万
  • 财政年份:
    2019
  • 负责人:
    Anna J. Esbensen
  • 依托单位:
海外基金